Haematology

Immuno-Oncology Summit

https://pharmaphorum.com/events/immuno-oncology-summit/

Novo Nordisk and Celgene lead January pharma M&A

https://pharmaphorum.com/news/novo-nordisk-celgene-lead-january-pharma-ma/

Novartis adds Promacta to breakthrough status roll-call

https://pharmaphorum.com/top-pharmaceutical-companies/novartis/fda-grants-novartis-drug-breakthrough-status-first-line-anaemia/

When science and biology combine – the outlook for ADCs in cancer drug development

https://pharmaphorum.com/partner-content-oncology/science-biology-combine-outlook-adcs-cancer-drug-development/

Ablynx files blood disorder drug in EU

https://pharmaphorum.com/news/ablynx-filed-blood-disorder-drug-eu/

Roche enters blood diagnostic market, promises faster results

https://pharmaphorum.com/news/roche-enters-blood-diagnostic-market-promises-faster-results/

As rituximab biosimilars close in, Roche showcases Gazyva superiority

https://pharmaphorum.com/news/rituximab-biosimilars-close-roche-showcases-gazyva-superiority/

CAR-Ts to take centre stage at ASH haematology congress

https://pharmaphorum.com/news/car-ts-take-centre-stage-haematology-congress/

Novartis buys sickle cell biotech Selexys

https://pharmaphorum.com/news/novartis-buys-us-biotech-selexys/

1 2

Close in 10 seconds

Pharmaphorum.com

Search